Acceder

Farmas USA

135K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
1.623 / 16.994
#12977

Re: Farmas USA

analisis bueno de AMRN

http://bionapcfa.blogspot.ca/2012/08/musing-on-amarin.html

sube un poco el precio tras el NCE
Those are my assumptions. All that gets me to $21.25. The model is below. I think if they can get NCE, the stock might be worth $23-24 on longer exclusivity. I think if REDUCE-IT hits, which there is precedence to believe it might, then my peak sales estimate of $2.5 billion is low - way low. Vascepa might do north of $4 billion in that case. That would put the stock above $30. But we will not know the outcome of REDUCE-IT for several years. With ANCHOR approved and REDUCE-IT looking good, I think then you might see a take-out. As I noted in my Tweet, I love the idea of AstraZeneca taking Amarin over. It just makes the most sense to me. Others like Lilly, Pfizer, Sanofi, Bristol, and Abbott also make sense.

#12979

Re: Farmas USA

claro claro, ese es el tema...

mas vale ver por donde va, y cogerla un poco mas alta cuando se vea que vaya subiendo, que cojas precio y aun le quede por bajar bastante...(aprendido ya de mi compra de AMRN..jaja)

#12982

Re: Farmas USA

ummmm...
cogemos la parte buena, por lo menos ven mejor ARNA que VVUS...

en tuiter
probably old news but... "Arena Pharma to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9"

sabiamos que habia esa conferencia? no me acuerdo ya con tanto dato!!

#12983

Re: Farmas USA

A ver Solrac, que una vez reconociera que perdia aceite, no queria decir que fuera por me me va el pelo en el pecho, si no por que compre Deoleo en 0.63 ...

Pero aún asi, salgo agraciado en la foto....

#12984

Re: Farmas USA

parece que ARNA se recupera , a ver a ver

Te puede interesar...

- No hay entradas a destacar -

- No hay entradas a destacar -

Brokers destacados